SDCCAG1 Inhibitors represent a category of chemical compounds designed to target and modulate the function of the SDCCAG1 protein. SDCCAG1, also known as serologically defined colon cancer antigen 1, is a protein involved in various cellular processes, including cell signaling, intracellular trafficking, and potentially immune response regulation. Inhibitors specific to SDCCAG1 are engineered to interfere with its activity, impacting the functions and pathways associated with this protein within the cell.
The mechanism of action of SDCCAG1 inhibitors typically involves binding to specific sites or domains within the SDCCAG1 protein. Through this interaction, these inhibitors may disrupt the protein's role in cellular signaling cascades, potentially affecting signaling pathways or intracellular trafficking processes. Researchers utilize SDCCAG1 inhibitors as essential tools to investigate the diverse functions of SDCCAG1 in cellular biology, shedding light on its impact on cellular processes and potentially revealing insights into its contributions to cellular homeostasis and immune responses. By probing the function of SDCCAG1 through inhibition, scientists aim to uncover the underlying molecular mechanisms that govern a wide range of cellular activities.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MLN 8054 | 869363-13-3 | sc-484828 | 5 mg | $398.00 | ||
MLN8054 is an inhibitor of Aurora A kinase, disrupting cell cycle progression, indirectly impacting SDCCAG1 regulation. | ||||||
AZD1152-HQPA | 722544-51-6 | sc-265334 | 10 mg | $375.00 | ||
AZD1152 is a selective inhibitor of Aurora B kinase, affecting mitotic processes and SDCCAG1 regulation indirectly. | ||||||
ZM-447439 | 331771-20-1 | sc-200696 sc-200696A | 1 mg 10 mg | $153.00 $356.00 | 15 | |
ZM447439 inhibits both Aurora A and B kinases, disrupting cell division and impacting SDCCAG1 expression indirectly. | ||||||
Reversine | 656820-32-5 | sc-203236 | 5 mg | $221.00 | 13 | |
Reversine is an ATP-competitive inhibitor of Aurora A and B kinases, disrupting mitotic processes and SDCCAG1 indirectly. | ||||||
ON-01910 | 1225497-78-8 | sc-364556 sc-364556A | 5 mg 10 mg | $300.00 $700.00 | ||
ON-01910 is a multi-kinase inhibitor, including PLK1, disrupting mitosis and cell cycle events, indirectly impacting SDCCAG1. | ||||||